Literature DB >> 25975989

Regulation of gene expression by CAR: an update.

Kaoru Kobayashi1, Mari Hashimoto, Paavo Honkakoski, Masahiko Negishi.   

Abstract

The constitutive androstane receptor (CAR), a member of the nuclear receptor superfamily, is a well-known xenosensor that regulates hepatic drug metabolism and detoxification. CAR activation can be elicited by a large variety of xenobiotics, including phenobarbital (PB) which is not a directly binding CAR ligand. The mechanism of CAR activation is complex and involves translocation from the cytoplasm into the nucleus, followed by further activation steps in the nucleus. Recently, epidermal growth factor receptor (EGFR) has been identified as a PB-responsive receptor, and PB activates CAR by inhibiting the EGFR signaling. In addition to regulation of drug metabolism, activation of CAR has multiple biological end points such as modulation of xenobiotic-elicited liver injury, and the role of CAR in endobiotic functions such as glucose metabolism and cholesterol homeostasis is increasingly recognized. Thus, investigations on the molecular mechanism of CAR activation are critical for the real understanding of CAR-mediated processes. Here, we summarize the current understanding of mechanisms by which CAR activators regulate gene expression through cellular signaling pathways and the roles of CAR on xenobiotic-elicited hepatocellular carcinoma, liver injury, glucose metabolism and cholesterol homeostasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25975989     DOI: 10.1007/s00204-015-1522-9

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  20 in total

1.  Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.

Authors:  Bryan Mackowiak; Linhao Li; Matthew A Welch; Daochuan Li; Jace W Jones; Scott Heyward; Maureen A Kane; Peter W Swaan; Hongbing Wang
Journal:  Mol Pharmacol       Date:  2017-04-25       Impact factor: 4.436

2.  Candidate genes responsible for early key events of phenobarbital-promoted mouse hepatocellular tumorigenesis based on differentiation of regulating genes between wild type mice and humanized chimeric mice.

Authors:  Ayako Ohara; Yasuhiko Takahashi; Miwa Kondo; Yu Okuda; Shuji Takeda; Masahiko Kushida; Kentaro Kobayashi; Kayo Sumida; Tomoya Yamada
Journal:  Toxicol Res (Camb)       Date:  2017-08-24       Impact factor: 3.524

Review 3.  Nuclear receptors and nonalcoholic fatty liver disease.

Authors:  Matthew C Cave; Heather B Clair; Josiah E Hardesty; K Cameron Falkner; Wenke Feng; Barbara J Clark; Jennifer Sidey; Hongxue Shi; Bashar A Aqel; Craig J McClain; Russell A Prough
Journal:  Biochim Biophys Acta       Date:  2016-03-04

Review 4.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

5.  Impact of Neonatal Activation of Nuclear Receptor CAR (Nr1i3) on Cyp2 Gene Expression in Adult Mouse Liver.

Authors:  Aram Shin; David J Waxman
Journal:  Toxicol Sci       Date:  2022-05-26       Impact factor: 4.109

6.  Sex-Differential Responses of Tumor Promotion-Associated Genes and Dysregulation of Novel Long Noncoding RNAs in Constitutive Androstane Receptor-Activated Mouse Liver.

Authors:  Nicholas J Lodato; Tisha Melia; Andy Rampersaud; David J Waxman
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

7.  Impact of CAR Agonist Ligand TCPOBOP on Mouse Liver Chromatin Accessibility.

Authors:  Nicholas J Lodato; Andy Rampersaud; David J Waxman
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

8.  Predicting Organ Toxicity Using in Vitro Bioactivity Data and Chemical Structure.

Authors:  Jie Liu; Grace Patlewicz; Antony J Williams; Russell S Thomas; Imran Shah
Journal:  Chem Res Toxicol       Date:  2017-10-09       Impact factor: 3.739

9.  p38 MAP Kinase Links CAR Activation and Inactivation in the Nucleus via Phosphorylation at Threonine 38.

Authors:  Takeshi Hori; Rick Moore; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2016-04-13       Impact factor: 3.922

10.  The Anti-Cancer Drug Dabrafenib Is a Potent Activator of the Human Pregnane X Receptor.

Authors:  Nicolas Creusot; Matthieu Gassiot; Elina Alaterre; Barbara Chiavarina; Marina Grimaldi; Abdelhay Boulahtouf; Lucia Toporova; Sabine Gerbal-Chaloin; Martine Daujat-Chavanieu; Alice Matheux; Roger Rahmani; Céline Gongora; Alexandre Evrard; Philippe Pourquier; Patrick Balaguer
Journal:  Cells       Date:  2020-07-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.